A health sciences and regulatory company is expanding its services to the European Union’s medical device, pharmaceutical and manufacturing industries.
Prosystem, an NSF company, is opening a new regulatory training facility in Hamburg in anticipation of a rise in the need for regulatory education as the deadline for the European Union Medical Device Regulation (EU MDR) 2017/745 and the In Vitro Diagnostic Medical Devices Regulation (EU IVDR) 2017/746, both adopted in 2017, enters into force on May 26, 2020.
Oliver Christ, executive vice president of Prosystem, said: “In the last 12 months, NSF International has invested strategically in European regulatory training, by adding eight new positions to our Hamburg team, which will help our clients in many ways. NSF’s new training centre in Germany expands our regulatory training and education programs to better support medical device and pharmaceutical manufacturers competing in the fast-changing European marketplace.”
